The study was conducted by scientists from health analytics organization Epic Research.
They also looked at diabetic and nondiabetic patients separately.
And the lowest associated risks were seen with the newest drugs on the market.
A container of Ozempic, which is taken via injection once a week.Photo: fcm82 (Shutterstock)
And these kinds of observational studies can only show a correlation between two factors, not causation.
And its certainly possible that some people can develop mental health or other complications from taking GLP-1s.
But for now, the overall safety profile of these drugs appears to still be on solid ground.
News from the future, delivered to your present.
A Staggering Number of U.S.
